Home › Chronic-Phase Myeloid Leukemia › North Carolina
Chronic-Phase Myeloid Leukemia clinical trials in North Carolina
3 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in North Carolina.
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
- Atrium Health Levine Cancer Institute, Winston-Salem
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06163430Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1019, Greenville
- Ascentage Investigative Site #1043, Morrisville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911Registry of Older Patients With Cancer
- Seby B. Jones Cancer Center, Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
- East Carolina University, Greenville
- and 4 more
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.